StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
46
This month
1
This week
1
This year
5
Today
1
Yesterday
1
Publishing Date
2024 - 04 - 19
1
2024 - 02 - 22
1
2024 - 02 - 14
1
2024 - 02 - 06
1
2024 - 02 - 02
1
2023 - 08 - 16
1
2023 - 06 - 30
1
2023 - 06 - 27
1
2023 - 06 - 08
1
2023 - 06 - 01
1
2023 - 05 - 26
1
2023 - 05 - 15
1
2023 - 05 - 10
1
2023 - 04 - 27
1
2023 - 04 - 07
1
2023 - 04 - 05
1
2023 - 03 - 11
1
2023 - 03 - 06
1
2023 - 02 - 28
1
2023 - 02 - 20
1
2023 - 01 - 30
1
2023 - 01 - 19
2
2023 - 01 - 12
1
2023 - 01 - 06
1
2022 - 12 - 28
1
2022 - 12 - 23
1
2022 - 12 - 15
1
2022 - 08 - 15
1
2022 - 08 - 05
1
2022 - 08 - 03
1
2022 - 07 - 29
2
2022 - 07 - 20
1
2022 - 07 - 11
1
2022 - 06 - 23
1
2022 - 04 - 27
1
2022 - 04 - 26
1
2022 - 03 - 23
1
2022 - 03 - 21
1
2022 - 03 - 08
1
2022 - 03 - 04
1
2022 - 02 - 16
1
2022 - 02 - 11
1
2022 - 02 - 02
1
2022 - 01 - 25
1
Sector
Health technology
46
Manufacturing
5
N/a
1
Process industries
1
Professional, scientific, and technical services
3
Tags
Alliances
16
Antibody
7
Application
11
Approval
20
Asia
15
Biotech
6
Biotech-bay
10
Biotech-beach
17
Cabometyx
7
Cancer
34
Cell carcinoma
7
Children
7
Clinical-trials-phase-ii
10
Clinical-trials-phase-iii
23
Collaboration
15
Covid
11
Covid-19
10
Disease
33
Drug
29
Earnings
23
Events
8
Expected
7
Fda
17
Financial
17
Financial results
13
Gene therapies
6
Gene therapy
6
Genetown
22
Global
51
Growth
29
Hereditary angioedema
8
Injection
6
Japan
7
License
13
Liver
16
Market
85
Money
11
N/a
185
Nivolumab
6
Partnership
6
People
7
Pharmaceutical
17
Phase 2
6
Phase 3
19
Positive
14
Product-news
10
Rare
11
Reach
12
Renal
7
Report
46
Research
41
Results
58
Sars-cov-2
6
Study
8
Takhzyro
7
Therapeutics
37
Therapy
43
Treatment
50
Trial
36
Vaccine
27
Entities
Abbott laboratories
4
Abbvie inc.
10
Adma biologics inc
1
Affimed n.v.
1
Albemarle corporation
1
Alkermes plc
1
Amgen inc.
6
Arcturus therapeutics holdings inc.
3
Arma services inc
1
Arrowhead pharmaceuticals, inc.
1
Astellas pharma inc
3
Astrazeneca plc
16
Bausch health companies inc.
2
Baxter international inc.
2
Biogen inc.
2
Biontech se
1
Bristol-myers squibb company
12
Catalent, inc.
1
Celldex therapeutics, inc.
1
Csl ltd
1
Eli lilly and company
14
Fate therapeutics, inc.
1
G1 therapeutics, inc.
1
Galapagos nv
1
Genmab a/s
2
Gilead sciences, inc.
4
Glaxosmithkline plc
12
Innate pharma sa
1
Jazz pharmaceuticals plc
1
Johnson & johnson
19
Kamada ltd.
1
Lineage cell therapeutics, inc.
1
Logicbio therapeutics, inc.
1
Lonza group ag
2
Medigus ltd.
1
Mirum pharmaceuticals, inc.
1
Neurocrine biosciences, inc.
2
Nkarta, inc.
1
Novartis ag
18
Novo nordisk a/s
4
Obseva sa
1
Perrigo company
1
Pfizer, inc.
10
Regeneron pharmaceuticals, inc.
1
Rigel pharmaceuticals, inc.
1
Sanofi
18
Stryker corporation
1
Takeda pharmaceutical company limited
46
Teva pharmaceutical industries limited
1
Teva pharmaceutical industries ltd
7
Thermo fisher scientific inc
3
Turning point therapeutics, inc.
1
U.s. stem cell, inc.
1
Ucb s.a.
3
Vericel corporation
1
Vertex pharmaceuticals incorporated
2
Symbols
A
90
AAPL
120
ABB
199
ABBV
97
ABLZF
199
ABT
306
ACM
94
ARVL
149
AZN
94
AZNCF
94
BDX
182
BIO
122
BSX
86
CNHI
81
CSCO
118
DD
90
DHR
184
DNZOF
97
DNZOY
97
DOW
83
ERIC
250
FNCTF
251
GE
180
GLAXF
137
GOOG
87
GOOGL
87
GSK
139
HON
314
IBM
96
IFNNF
97
IFNNY
97
INTC
166
JNJ
345
LIN
77
LLY
140
LMT
155
MDT
165
MMM
194
MSFT
268
NIPNF
116
NOC
127
NVDA
75
NVS
195
NVSEF
194
ORCL
204
PCRFF
148
PCRFY
148
PHG
174
QGEN
94
RACE
79
RTX
94
SAP
162
SAPGF
161
SNY
312
SNYNF
307
SYK
82
TEVJF
95
TMO
307
XOM
92
ZTCOF
85
Exchanges
Amex
1
Nasdaq
40
Nyse
46
Crawled Date
2024 - 04 - 19
1
2024 - 02 - 22
1
2024 - 02 - 14
1
2024 - 02 - 07
1
2024 - 02 - 02
1
2023 - 08 - 16
1
2023 - 06 - 30
1
2023 - 06 - 27
1
2023 - 06 - 08
1
2023 - 06 - 01
1
2023 - 05 - 27
1
2023 - 05 - 15
1
2023 - 05 - 10
1
2023 - 04 - 28
1
2023 - 04 - 07
1
2023 - 04 - 05
1
2023 - 03 - 11
1
2023 - 03 - 06
1
2023 - 02 - 28
1
2023 - 02 - 20
1
2023 - 01 - 30
1
2023 - 01 - 19
2
2023 - 01 - 12
1
2023 - 01 - 06
1
2022 - 12 - 28
1
2022 - 12 - 23
1
2022 - 12 - 15
1
2022 - 08 - 15
1
2022 - 08 - 05
1
2022 - 08 - 03
1
2022 - 07 - 29
2
2022 - 07 - 20
1
2022 - 07 - 11
1
2022 - 06 - 23
1
2022 - 04 - 27
1
2022 - 04 - 26
1
2022 - 03 - 23
1
2022 - 03 - 21
1
2022 - 03 - 08
1
2022 - 03 - 04
1
2022 - 02 - 16
1
2022 - 02 - 11
1
2022 - 02 - 03
1
2022 - 01 - 25
1
Crawled Time
00:00
3
00:20
1
01:00
3
02:00
3
03:00
1
04:20
1
08:00
1
10:00
1
11:00
2
12:00
3
12:20
1
13:00
2
13:20
1
13:30
1
14:00
1
15:00
1
15:20
2
16:00
1
17:00
5
18:00
3
19:00
1
20:00
2
21:00
1
22:00
3
23:00
2
Source
www.biospace.com
5
www.prnewswire.com
41
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Report
symbols :
TAK
save search
Progressive Familial Intrahepatic Cholestasis Treatment Market Projected to Reach $156.14 million by 2030 - Exclusive Report by 360iResearch
Published:
2024-04-19
(Crawled : 02:00)
- prnewswire.com
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
Email alert
Add to watchlist
TAK
|
News
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
Email alert
Add to watchlist
MIRM
|
$23.6
-1.05%
-1.06%
400K
|
Health Technology
|
Email alert
Add to watchlist
report
million
reach
treatment
market
Plasma Therapy Global Market Report 2024 - Projected Compound Annual Growth Rate of 12.5%, with Market Set to Reach $0.88 Billion in 2028
Published:
2024-02-22
(Crawled : 01:00)
- prnewswire.com
TAK
|
News
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
-10.79%
|
O:
-0.2%
H:
0.14%
C:
-0.48%
BAX
|
$39.65
0.33%
0.0%
2.3M
|
Health Technology
|
-5.99%
|
O:
-0.38%
H:
0.14%
C:
-0.14%
KMDA
|
$5.075
-0.1%
-0.1%
6.5K
|
Health Technology
|
-15.22%
|
O:
2.0%
H:
2.28%
C:
1.63%
ADMA
4
|
$6.21
2.82%
2.74%
3M
|
Health Technology
|
19.69%
|
O:
0.19%
H:
2.5%
C:
1.35%
report
reach
global
set
therapy
growth
market
Protein Inhibitors Global Market Report 2024 - A $125 Billion Market in 2028, Registering Compound Annual Growth of 9%
Published:
2024-02-14
(Crawled : 02:00)
- prnewswire.com
LZAGF
|
$579.0
-19.1%
49
|
Health Technology
|
12.7%
|
O:
3.14%
H:
1.92%
C:
1.92%
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
-3.81%
|
O:
-2.14%
H:
0.0%
C:
-0.63%
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
-0.29%
|
O:
-2.71%
H:
0.0%
C:
0.0%
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
9.56%
|
O:
0.87%
H:
0.21%
C:
-2.23%
LZAGY
|
$57.3
0.02%
33K
|
Professional, Scientific, and T...
|
15.41%
|
O:
4.07%
H:
1.53%
C:
1.45%
TMO
|
News
|
$541.52
-1.05%
0.61%
2.1M
|
Health Technology
|
-1.04%
|
O:
0.56%
H:
1.3%
C:
1.22%
TAK
|
News
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
-8.3%
|
O:
0.42%
H:
1.04%
C:
0.97%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-8.08%
|
O:
-0.91%
H:
0.0%
C:
0.0%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
-4.32%
|
O:
0.89%
H:
0.41%
C:
0.1%
LLY
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
1.05%
|
O:
0.38%
H:
2.44%
C:
1.54%
BAX
|
$39.65
0.33%
0.0%
2.3M
|
Health Technology
|
0.2%
|
O:
0.33%
H:
0.63%
C:
-0.28%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
-5.33%
|
O:
-0.73%
H:
0.0%
C:
0.0%
ABT
|
News
|
$105.27
-0.6%
-0.15%
7.3M
|
Health Technology
|
-5.49%
|
O:
-0.83%
H:
0.66%
C:
0.38%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-1.43%
|
O:
-1.1%
H:
0.0%
C:
0.0%
GLPG
|
$28.9
-1.1%
-1.11%
140K
|
Health Technology
|
-25.19%
|
O:
-1.72%
H:
1.8%
C:
1.59%
BIIB
|
$190.55
-0.84%
-0.84%
1.5M
|
Health Technology
|
-13.9%
|
O:
0.16%
H:
0.43%
C:
-2.76%
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
11.85%
|
O:
0.28%
H:
0.93%
C:
0.75%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
-8.79%
|
O:
-0.21%
H:
0.34%
C:
0.07%
report
global
protein
growth
market
Blood Cancer Drugs Market Report 2023: Reveals Striking Growth Prospects with a Surge in R&D Activities - Long-term Forecasts to 2028 and 2033
Published:
2024-02-06
(Crawled : 00:00)
- prnewswire.com
ALPMF
|
$9.594
43.47%
2.2K
|
Health Technology
|
-13.72%
|
O:
-1.53%
H:
0.0%
C:
0.0%
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
1.09%
|
O:
-0.37%
H:
0.0%
C:
0.0%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-8.98%
|
O:
0.41%
H:
0.0%
C:
0.0%
UCBJY
|
$64.07
-4.38%
72K
|
Manufacturing
|
37.02%
|
O:
1.71%
H:
1.28%
C:
0.94%
ALPMY
|
$9.46
-1.11%
500K
|
Manufacturing
|
-14.23%
|
O:
0.28%
H:
0.18%
C:
0.0%
TAK
|
News
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
-7.13%
|
O:
0.07%
H:
0.42%
C:
0.07%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-10.28%
|
O:
0.09%
H:
0.39%
C:
-0.36%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-6.93%
|
O:
1.47%
H:
0.0%
C:
0.0%
LLY
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
6.49%
|
O:
0.76%
H:
4.31%
C:
2.11%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-1.95%
|
O:
-0.14%
H:
0.35%
C:
-1.12%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
-3.43%
|
O:
1.48%
H:
0.0%
C:
0.0%
VRTX
|
News
|
$393.51
0.1%
0.1%
950K
|
Health Technology
|
-5.09%
|
O:
0.15%
H:
2.4%
C:
0.56%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-2.19%
|
O:
1.33%
H:
0.0%
C:
0.0%
JAZZ
|
$109.3
2.05%
2.01%
560K
|
Health Technology
|
-14.12%
|
O:
-0.02%
H:
0.0%
C:
-1.4%
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
1.83%
|
O:
-0.4%
H:
0.19%
C:
-0.33%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
-16.18%
|
O:
-0.18%
H:
0.0%
C:
-6.22%
report
cancer
blood
growth
market
United States Endometrial Cancer Research Report 2023
Published:
2024-02-02
(Crawled : 10:00)
- prnewswire.com
TAK
|
News
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
-8.55%
|
O:
0.21%
H:
0.49%
C:
-0.9%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-11.63%
|
O:
-0.5%
H:
0.26%
C:
-1.03%
report
cancer
research
Global Hemophilia Research Analysis Report 2023: A $21.07 Billion Market by 2030 - Approval of Gene Therapies and Monoclonal Antibodies Fueling Growth
Published:
2023-08-16
(Crawled : 01:00)
- prnewswire.com
TAK
|
News
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
-13.43%
|
O:
-0.26%
H:
0.26%
C:
-0.46%
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-28.17%
|
O:
-0.71%
H:
1.45%
C:
0.97%
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
34.55%
|
O:
-0.3%
H:
1.35%
C:
0.05%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-14.49%
|
O:
-1.33%
H:
0.0%
C:
0.0%
report
approval
research
global
growth
market
Global CNS Therapeutics Strategic Business Report 2023: Burgeoning Global Aging Populace, Longer Life Expectancy to Drive CNS Demand
Published:
2023-06-30
(Crawled : 23:00)
- prnewswire.com
ALKS
|
$23.78
-0.96%
-0.97%
1.8M
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
Email alert
Add to watchlist
NBIX
M
|
$132.49
-0.56%
-0.56%
550K
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
Email alert
Add to watchlist
UCBJY
|
$64.07
-4.38%
72K
|
Manufacturing
|
Email alert
Add to watchlist
UCBJF
|
$126.05
-39.66%
100
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
Email alert
Add to watchlist
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
Email alert
Add to watchlist
TAK
|
News
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
Email alert
Add to watchlist
report
business
life
global
therapeutics
Global Cancer Therapies Strategic Business Report 2023: Industry Focuses on New Approaches to Treat Cancer
Published:
2023-06-27
(Crawled : 01:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
11.2%
|
O:
-1.1%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
-16.61%
|
O:
-0.95%
H:
0.19%
C:
-0.32%
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-31.09%
|
O:
0.19%
H:
0.11%
C:
-1.46%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-6.46%
|
O:
-0.01%
H:
0.16%
C:
-0.32%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-11.42%
|
O:
0.03%
H:
0.12%
C:
-0.24%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
9.18%
|
O:
-0.91%
H:
0.56%
C:
-0.5%
LLY
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
65.82%
|
O:
2.15%
H:
1.18%
C:
0.43%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-25.45%
|
O:
-0.06%
H:
0.46%
C:
0.0%
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
-4.83%
|
O:
-0.21%
H:
0.42%
C:
0.13%
report
business
cancer
treat
global
Global Peptide Therapeutics Market Report 2023: Increasing Prevalence of Cancer and Metabolic Disorders Drives Growth
Published:
2023-06-08
(Crawled : 02:00)
- prnewswire.com
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
-7.89%
|
O:
0.07%
H:
0.0%
C:
-1.7%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
14.25%
|
O:
1.32%
H:
0.0%
C:
-0.62%
TAK
|
News
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
-18.27%
|
O:
-0.62%
H:
0.88%
C:
0.81%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-5.5%
|
O:
1.26%
H:
1.08%
C:
0.91%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
15.25%
|
O:
0.41%
H:
0.68%
C:
0.64%
LLY
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
72.05%
|
O:
-0.11%
H:
2.66%
C:
2.24%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-25.87%
|
O:
0.28%
H:
0.42%
C:
-0.05%
BNTX
|
$86.19
-0.24%
-0.24%
580K
|
Health Technology
|
-21.24%
|
O:
0.39%
H:
0.15%
C:
-0.79%
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
-6.88%
|
O:
-0.23%
H:
1.83%
C:
1.52%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
19.74%
|
O:
0.0%
H:
0.28%
C:
-0.23%
metabolic
report
cancer
global
therapeutics
growth
market
Peptide Therapeutics Global Market Report 2023: Increase in the Prevalence of Chronic Diseases Drives Growth
Published:
2023-06-01
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
-8.59%
|
O:
-0.56%
H:
0.0%
C:
0.0%
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
-8.39%
|
O:
-0.74%
H:
1.4%
C:
0.35%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
15.61%
|
O:
0.99%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
-17.24%
|
O:
1.32%
H:
0.31%
C:
0.12%
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-33.14%
|
O:
0.6%
H:
1.07%
C:
0.29%
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
-21.17%
|
O:
-1.84%
H:
1.62%
C:
1.33%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-4.15%
|
O:
1.03%
H:
0.84%
C:
0.82%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-25.32%
|
O:
0.37%
H:
1.34%
C:
1.14%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-9.41%
|
O:
1.05%
H:
0.0%
C:
0.0%
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
-6.28%
|
O:
0.11%
H:
0.69%
C:
-0.45%
report
global
therapeutics
growth
market
Global Addiction Treatment Market Report 2023: Sector to Reach $11.7 Billion by 2031 at a 6.1% CAGR
Published:
2023-05-26
(Crawled : 00:20)
- prnewswire.com
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
SYK
|
$327.45
-2.55%
0.0%
2.1M
|
Health Technology
|
Email alert
Add to watchlist
TAK
|
News
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
Email alert
Add to watchlist
report
reach
treatment
global
market
Targeted Therapy Global Market Report 2023: Increasing Prevalence of Cancer Drives Growth
Published:
2023-05-15
(Crawled : 17:00)
- prnewswire.com
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
-33.14%
|
O:
0.24%
H:
0.66%
C:
0.66%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
7.89%
|
O:
-1.1%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
-19.72%
|
O:
0.61%
H:
0.3%
C:
0.24%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-9.75%
|
O:
0.2%
H:
0.13%
C:
-0.22%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
8.4%
|
O:
0.27%
H:
0.6%
C:
0.41%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-15.86%
|
O:
0.38%
H:
0.0%
C:
0.0%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
-31.57%
|
O:
0.38%
H:
0.91%
C:
0.69%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
13.73%
|
O:
0.14%
H:
0.28%
C:
0.11%
report
cancer
global
therapy
growth
market
Global Gaucher's Disease Treatment Market Research Report 2023: Emerging Therapies, Clinical Trials, Treatments, Current Scenario Evaluation, Patient Profile
Published:
2023-05-10
(Crawled : 18:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
8.88%
|
O:
0.92%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
-22.56%
|
O:
-1.83%
H:
0.12%
C:
-3.06%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-10.18%
|
O:
-0.4%
H:
0.34%
C:
0.19%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-10.33%
|
O:
0.11%
H:
0.22%
C:
-0.52%
ABT
|
News
|
$105.27
-0.6%
-0.15%
7.3M
|
Health Technology
|
-3.88%
|
O:
-0.57%
H:
0.37%
C:
-0.01%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-15.88%
|
O:
-0.28%
H:
0.0%
C:
0.0%
disease
report
treatment
research
global
market
Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Report 2023: New Drug Launches and Growing Awareness Fuels $32 Billion Industry
Published:
2023-04-27
(Crawled : 00:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
14.12%
|
O:
0.23%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
-22.0%
|
O:
-1.13%
H:
0.3%
C:
-0.48%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-9.32%
|
O:
-0.79%
H:
0.89%
C:
0.72%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-11.07%
|
O:
-0.12%
H:
0.58%
C:
0.55%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
9.97%
|
O:
-0.25%
H:
0.97%
C:
0.31%
LLY
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
92.33%
|
O:
1.96%
H:
1.59%
C:
-0.54%
drug
report
treatment
global
growing
market
Ulcerative Colitis Drug Global Market Report 2022: Increasing Prevalence of Ulcerative Colitis and Inflammatory Bowel Diseases Bolsters Sector
Published:
2023-04-07
(Crawled : 11:00)
- prnewswire.com
TAK
|
News
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
BHC
|
$8.6
-0.69%
0.0%
2.1M
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
Email alert
Add to watchlist
drug
report
global
market
Stem Cell Therapy Global Market Report 2022: Advancements in Stem Cell Clinical Trials Fuels Growth
Published:
2023-04-05
(Crawled : 23:00)
- prnewswire.com
TAK
|
News
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
-20.5%
|
O:
1.24%
H:
2.42%
C:
1.94%
report
cell
trials
global
therapy
growth
market
Endometriosis Drugs Global Market Report 2023: Emerging Treatments for Endometriosis & Endometrial Cancer Present Opportunities
Published:
2023-03-11
(Crawled : 04:20)
- prnewswire.com
ALPMF
|
$9.594
43.47%
2.2K
|
Health Technology
|
Email alert
Add to watchlist
TAK
|
News
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
Email alert
Add to watchlist
OBSV
|
$0.1018
-15.52%
-18.95%
8.2M
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
Email alert
Add to watchlist
ALPMY
|
$9.46
-1.11%
500K
|
Manufacturing
|
Email alert
Add to watchlist
global
report
cancer
market
Global API and Pharmaceutical Excipients Market Report 2022-2029 Featuring Catalent, Divis Labs, Euroapi Lonza, Pfizer, Samsung Biologics, Teva, Thermo Fisher Scientific, Wuxi Apptec, & Wuxi Biologics
Published:
2023-03-06
(Crawled : 20:00)
- prnewswire.com
CMXHF
|
$172.54
-19.21%
50
|
n/a
|
-10.86%
|
O:
-0.86%
H:
0.33%
C:
0.33%
CSLLY
|
$87.96
3.3%
45K
|
n/a
|
-11.33%
|
O:
-0.02%
H:
0.54%
C:
-1.7%
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
3.92%
|
O:
-2.57%
H:
1.62%
C:
1.62%
TMO
|
News
|
$541.52
-1.05%
0.61%
2.1M
|
Health Technology
|
-4.57%
|
O:
0.41%
H:
0.39%
C:
-2.14%
TEVA
|
$12.78
-3.03%
-0.24%
9M
|
Health Technology
|
33.0%
|
O:
-1.21%
H:
0.43%
C:
-3.58%
TAK
|
News
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
-15.92%
|
O:
0.83%
H:
0.06%
C:
-1.2%
PRGO
|
$29.94
-0.33%
0.0%
970K
|
Health Technology
|
-18.72%
|
O:
0.76%
H:
1.91%
C:
1.26%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
14.95%
|
O:
0.32%
H:
0.17%
C:
-1.53%
LLY
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
135.38%
|
O:
0.01%
H:
0.42%
C:
-2.62%
CTLT
|
$55.8
-0.29%
0.0%
1M
|
Health Technology
|
-21.81%
|
O:
0.11%
H:
0.53%
C:
-5.05%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-29.9%
|
O:
0.41%
H:
0.04%
C:
-1.71%
ALB
|
News
|
$111.8
-2.26%
0.63%
2.2M
|
Process Industries
|
-55.43%
|
O:
-0.95%
H:
1.02%
C:
-2.19%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
6.36%
|
O:
0.19%
H:
0.06%
C:
-1.7%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-4.65%
|
O:
0.65%
H:
0.0%
C:
0.0%
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
-17.52%
|
O:
0.23%
H:
0.0%
C:
-1.25%
BIIB
|
$190.55
-0.84%
-0.84%
1.5M
|
Health Technology
|
-27.79%
|
O:
0.28%
H:
0.0%
C:
-2.26%
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
5.74%
|
O:
0.9%
H:
0.28%
C:
-1.3%
global
report
market
Global Intravenous (IV) Iron Drugs Market Report 2022: Clinical Trials, Industry Size, Share, Trends, Opportunities, and Forecasts, 2018-2028
Published:
2023-02-28
(Crawled : 03:00)
- prnewswire.com
TAK
|
News
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
-14.55%
|
O:
-0.13%
H:
0.13%
C:
-0.13%
BHC
|
$8.6
-0.69%
0.0%
2.1M
|
Health Technology
|
-6.32%
|
O:
-0.11%
H:
1.61%
C:
-0.11%
global
report
market
Antacids Global Market Report 2023
Published:
2023-02-20
(Crawled : 18:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
Email alert
Add to watchlist
TAK
|
News
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
Email alert
Add to watchlist
ABT
|
News
|
$105.27
-0.6%
-0.15%
7.3M
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
global
report
market
← Previous
1
2
3
Next →
Gainers vs Losers
64%
36%
Top 10 Gainers
AGBA
|
News
|
$1.02
155.0%
57.94%
120M
|
Finance
ZCMD
|
$2.86
108.76%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.555
104.6%
51.13%
5M
|
Health Technology
ISPC
|
$0.437
105.16%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
News
|
$0.92
84.0%
45.65%
1.6M
|
OST
|
$0.499
21.38%
45.26%
1.9M
|
XPON
|
News
|
$3.1
60.62%
37.74%
17M
|
TIRX
|
$0.7
44.39%
30.74%
58M
|
BNTC
|
News
|
$6.92
44.17%
30.64%
3.5M
|
Health Technology
GGE
|
$0.035
19.86%
29.3%
64M
|
Your saved searches
Save your searches and get alerts when important news are released.